Ajanta Pharma Ltd. (AJANTPHARM) Share Price Falls 3.13% Today
- August 5, 2026
- Posted by: Harsh Piplani
- Category: News
Ajanta Pharma Ltd. Share Price experienced a notable decline of 3.13% today, closing at Rs 3,412. This movement has brought the company’s market capitalization to Rs 43,921.22 crore. The stock opened at Rs 3,535.5, reaching a high of the same before falling to a low of Rs 3,412.
The decline in Ajanta Pharma Ltd. Share Price today is noteworthy as it surpasses the threshold for its market-cap category, indicating a substantial market reaction. While the data confirms the price event, it does not establish a specific catalyst behind this movement. Investors and analysts will be keen to understand the underlying factors contributing to this decline.
Ajanta Pharma Ltd. (AJANTPHARM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,412 |
| Previous Close | Rs 3,522.35 |
| Today's Change | Rs -110.35 (-3.13%) |
| Day Open | Rs 3,535.5 |
| Day High | Rs 3,535.5 |
| Day Low | Rs 3,412 |
| Current Volume (BSE) | 2,803 |
| BSE Traded Volume | 2,803 |
| NSE Traded Volume | 43,177 |
| Combined NSE + BSE Volume | 45,980 |
| Turnover | Rs 0.96 crore |
| Market Capitalisation | Rs 43,921.22 crore |
| Market Cap Category | Large Cap |
Ajanta Pharma Ltd. (AJANTPHARM) traded at Rs 3,412. versus the previous close of Rs 3,522.35, a fall of 3.13%. The stock opened at Rs 3,535.5, reached Rs 3,535.5, touched Rs 3,412. Reported volume was 2,803.
Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 43,921.22 crore |
Ajanta Pharma Ltd. operates within the Healthcare sector, a space known for its dynamic and ever-evolving nature. With a market capitalization of Rs 43,921.22 crore, the company is a significant player in its industry.
The Healthcare sector, as a whole, presents a diverse range of companies with varying performance metrics. The sector’s P/E median is 26.29, with an average of 91.55, indicating a broad spectrum of valuations. Ajanta Pharma Ltd.’s position within this sector suggests that it operates in a competitive environment with both opportunities and challenges.
While specific financial metrics such as EPS, book value, and dividend yield are not available, the company’s market cap and sector context provide a foundational understanding of its standing. Investors should consider these factors when evaluating Ajanta Pharma Ltd.’s potential and risks.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 26.29x |
| Benchmark Average P/E | 91.55x |
| Benchmark P/E Range | 3.39x to 3,385.56x |
| Benchmark Median P/B | 1.9x |
| Benchmark Median ROE | 10.77% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 43,921.22 crore |
| Benchmark Median Market Cap | Rs 136.63 crore |
Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare.
Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Ajanta Pharma Ltd. is part of the Healthcare sector, which includes a wide array of companies ranging from pharmaceuticals to healthcare services. The sector’s benchmark includes 198 companies, providing a comprehensive view of the industry’s landscape.
The median P/E ratio for the sector is 26.29, with a wide range from a minimum of 3.39 to a maximum of 3385.56. This variability highlights the diverse nature of companies within the sector. Ajanta Pharma Ltd.’s market cap places it among the larger entities in this space, suggesting a robust market presence.
The sector’s ROE and ROCE medians are 10.77% and 13.35%, respectively. These figures provide a benchmark for evaluating Ajanta Pharma Ltd.’s performance relative to its peers. Understanding these metrics is crucial for investors looking to assess the company’s efficiency and profitability within the sector.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,945.17 | 30.21 | 0.44 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,835.92 | 0 | 2.35 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,652.68 | 39.86 | 8.11 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,608.51 | 63.2 | 10 | 18.65 | 22.17 |
| Panacea Biotec Ltd. | PANACEABIO | 2,589.99 | 0 | 3.07 | 0 | 5.36 |
Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 43,921.22 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Ajanta Pharma Ltd. operates in a competitive landscape with several notable peers. Among them, Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,945.17 crore and a P/E ratio of 30.21. Hikal Ltd. and Kwality Pharmaceuticals Ltd. also present strong competition with market caps of Rs 2,835.92 crore and Rs 2,652.68 crore, respectively.
Comparing Ajanta Pharma Ltd. to these peers provides insights into its relative market position and valuation. While specific P/E and ROE figures for Ajanta Pharma Ltd. are not available, the peer data highlights the competitive dynamics within the sector.
Why Investors Are Watching Ajanta Pharma Ltd.
Ajanta Pharma Ltd. has captured investor attention due to its significant price movement and market position. Key factors include:
- Notable 3.13% price fall today, exceeding the Large Cap threshold.
- Active trading volume indicating heightened market interest.
- Position within the dynamic Healthcare sector.
- Competitive landscape with strong peers.
Investors should monitor Ajanta Pharma Ltd.’s future performance, considering both market trends and sector developments. Understanding the broader industry context and peer dynamics will be crucial in assessing the company’s potential.
About Ajanta Pharma Ltd.
Ajanta Pharma Ltd. is a prominent player in the Healthcare sector, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company operates across various therapeutic segments, catering to both domestic and international markets.
With a diverse product portfolio, Ajanta Pharma Ltd. addresses a wide range of medical needs, contributing to its strong market presence. The company’s commitment to innovation and quality positions it as a key player in the industry, navigating the challenges and opportunities within the Healthcare sector.
Track Ajanta Pharma Ltd. Share Price on Univest
Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Investors and analysts can track Ajanta Pharma Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on technical indicators, fundamental ratios, shareholding patterns, and market trends, offering valuable information for informed decision-making.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What caused Ajanta Pharma Ltd. Share Price to fall today?
Ans. Ajanta Pharma Ltd. Share Price fell 3.13% today, but the data does not specify a particular catalyst for this decline. The movement reflects broader market dynamics and sector conditions. The stock moved -3.13% during the session.
How did Ajanta Pharma Ltd. perform in today's trading session?
Ans. Ajanta Pharma Ltd. opened at Rs 3,535.5 and closed at Rs 3,412, marking a 3.13% decline. The stock experienced a high of Rs 3,535.5 and a low of Rs 3,412 during the session.
How does Ajanta Pharma Ltd. compare to its peers?
Ans. Ajanta Pharma Ltd. operates in a competitive landscape with peers like Dishman Carbogen Amcis Ltd. and Hikal Ltd. Peer comparisons highlight the competitive dynamics within the sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.
What is the sector context for Ajanta Pharma Ltd.?
Ans. Ajanta Pharma Ltd. is part of the Healthcare sector, which includes 198 companies. The sector's P/E median is 26.29, with a wide range of valuations and performance metrics. The stock belongs to the Healthcare sector.
What are the key factors influencing Ajanta Pharma Ltd.'s share price?
Ans. Ajanta Pharma Ltd.'s share price is influenced by market dynamics, sector trends, and competitive positioning within the Healthcare industry. The stock moved -3.13% during the session. The intraday range extended from Rs 3,412 to Rs 3,535.5.
What is Ajanta Pharma Ltd.'s position in the Healthcare sector?
Ans. Ajanta Pharma Ltd. is a significant player in the Healthcare sector, with a market cap of Rs 43,921.22 crore, operating in a competitive environment. The stock belongs to the Healthcare sector.
How can investors track Ajanta Pharma Ltd. Share Price?
Ans. Investors can track Ajanta Pharma Ltd. Share Price on Univest for real-time updates, technical indicators, and comprehensive market insights. The stock moved -3.13% during the session. The intraday range extended from Rs 3,412 to Rs 3,535.5.
